Nephrology and Dialysis, Interventional Nephrology Unit, Nuova ITOR, Rome, Italy.
U.O.C. Nefrologia Dialsi e Trapianto, A.O. S. Camillo Forlanini, INMI L. Spallanzani, Rome, Italy.
J Vasc Access. 2024 Jan;25(1):308-312. doi: 10.1177/11297298221109663. Epub 2022 Jul 13.
Arteriovenous fistula (AVF) is the preferred angioaccess for haemodialysis but suffers from a high stenosis rate, juxta-anastomotic stenosis (JAS) being the most frequent. Percutaneous transluminal angioplasty (PTA) of JAS would have some advantage (such as mini-invasive and vein sparing treatment), but higher recurrence rate is observed as compared to surgery. We report results of juxta anastomotic stenosis PTA using the 'double guide technique' (DGT) as described by Turmel-Rodrigues, in a selected cohort from our Vascular Access Centre.
From January to June 2018, 25 consecutive patients were treated by DGT. By means of retrograde access through the outflow vein by a 6 F introducer, two guide wires were navigated: one into proximal radial artery (GW1), the other into distal artery (GW2). GW2 was used to dilate juxta-anastomotic vein and anastomotic area with 6 mm high-pressure balloon, while by GW1 juxta-anastomotic artery was dilated with 4 mm semi-compliant balloon. Mean diameter of balloons were 6.7 and 4.1 mm for venous and arterial tract dilatation. Follow up was carried out up to 12 months. Prospectively collected data were analysed retrospectively.
One-year primary and secondary patency was 52% and 95% respectively. Recurrence rate was 0.56 procedure/pt/year. Mean access blood flow at 12 months was 830 ml/min.
Double Guidewire Technique is an effective and minimally invasive procedure. By avoiding under dilation of JAS the recurrence rate resulted quite satisfactorily in our population.
动静脉瘘(AVF)是血液透析的首选血管通路,但存在较高的狭窄率,其中吻合口旁狭窄(JAS)最为常见。经皮腔内血管成形术(PTA)治疗 JAS 具有一定优势(如微创、保留静脉),但与手术相比,其复发率更高。我们报告了采用 Turmel-Rodrigues 描述的“双导丝技术”(DGT)治疗 JAS 的结果,该技术在我们的血管通路中心的一个选定队列中进行。
2018 年 1 月至 6 月,25 例连续患者采用 DGT 治疗。通过远侧流出静脉的逆行通路,使用 6F 引入器,导丝 2 根:一根进入近端桡动脉(GW1),另一根进入远端动脉(GW2)。GW2 用于扩张吻合口旁静脉和吻合口区域,使用 6mm 高压球囊;而 GW1 用于扩张吻合口旁动脉,使用 4mm 半顺应性球囊。球囊的平均直径分别为 6.7mm 和 4.1mm 用于静脉和动脉通道扩张。随访时间最长为 12 个月。前瞻性收集的数据进行回顾性分析。
1 年原发性和继发性通畅率分别为 52%和 95%。复发率为 0.56/例/年。12 个月时的平均通路血流量为 830ml/min。
双导丝技术是一种有效且微创的方法。通过避免 JAS 扩张不足,我们的人群中复发率相当令人满意。